POU5F1 and cancer: Previous reports demonstrated that miR-375 enhances MET in various cancer models and β cell-derived cells.35, 36, 37 However, there is no existing report on the expression or involvement of miR-375 during reprogramming, making it an ideal candidate to regulate exogenous OCT4 without affecting reprogramming process.